| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6145844 | American Journal of Obstetrics and Gynecology | 2013 | 12 Pages |
Abstract
These findings suggest that drugs that modulate insulin sensitivity, such as metformin, hinder estrogen-mediated endometrial proliferation. Therefore, these drugs may be clinically useful for the prevention of endometrial cancer in obese women.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Qian PhD, Joseph PT, Rosemarie PhD, Adrienne S. PhD, Diana L. MS, Larissa A. MD, Jennifer K. MD, Marilyn MD, Melinda S. PhD, David MD, Russell R. MD, PhD, Karen H. MD,